Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]

1685 reported adverse events

Drugs of this class: ALGLUCOSIDASE ALFA AVALGLUCOSIDASE ALFA

These side effects are most commonly reported by patients taking drugs of the Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] class:

#	Side effect	Count
0	DYSPNOEA	113
1	PYREXIA	110
2	MALAISE	83
3	URTICARIA	79
4	OFF LABEL USE	77
5	INFUSION RELATED REACTION	70
6	RASH	68
7	PNEUMONIA	67
8	FALL	66
9	FATIGUE	66

See all common reactions for Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]

Drugs of the Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	URINARY HEXOSE TETRASACCHARIDE INCREASED	4	0.8000
1	NEUTRALISING ANTIBODIES NEGATIVE	4	0.1429
2	DRUG SPECIFIC ANTIBODY ABSENT	19	0.1397
3	COMPLEMENT FIXATION TEST POSITIVE	1	0.1111
4	ELECTROCARDIOGRAM PACEMAKER SPIKE	1	0.1111
5	DYSMYELINATION	1	0.0909
6	EAR TUBE REMOVAL	1	0.0833
7	CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	4	0.0755
8	TRACHEOSTOMY TUBE REMOVAL	2	0.0741
9	WINGED SCAPULA	2	0.0714

See all enriched reactions for Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]